Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liposomal Amphotericin B”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Post-approval studies (Phase 4)Study completedNCT03311607
What this trial is testing

Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh

Who this might be right for
Post-kala-azar Dermal Leishmaniasis
Medecins Sans Frontieres, Netherlands 280
Post-approval studies (Phase 4)Not Yet RecruitingNCT06754436
What this trial is testing

Population Pharmacokinetics of L-AmB in Chinese Patients Assisted by Extracorporeal Membrane Pulmonary Oxygenation (ECMO)

Who this might be right for
Invasive Fungal InfectionsLiposomal Amphotericin B
Beijing Anzhen Hospital 30
Early research (Phase 1)Study completedNCT04993222
What this trial is testing

A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects

Who this might be right for
Bioequivalence
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT07215273
What this trial is testing

Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected Invasive Mould Infections

Who this might be right for
Suspected Invasive Mould Infection
Elion Therapeutics, Inc. 80
Post-approval studies (Phase 4)Study completedNCT00670657
What this trial is testing

CRITIC - Treatment of Candidemia and Invasive Candidiasis

Who this might be right for
CandidemiaInvasive Candidiasis
Gilead Sciences 39
Not applicableLooking for participantsNCT07135778
What this trial is testing

Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD（ Breakthrough Invasive Fungal Disease） in Patients With Malignant Hematological Diseases

Who this might be right for
Invasive Fungal Disease
Institute of Hematology & Blood Diseases Hospital, China 36
Testing effectiveness (Phase 2)Study completedNCT00371995
What this trial is testing

Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 150
Large-scale testing (Phase 3)Study completedNCT00523965
What this trial is testing

Combination Therapy in Indian Visceral Leishmaniasis

Who this might be right for
Leishmaniasis, Visceral
Banaras Hindu University 624
Not applicableStudy completedNCT03511820
What this trial is testing

A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever

Who this might be right for
Neutropenia, Febrile
TTY Biopharm 54
Testing effectiveness (Phase 2)Study completedNCT04059770
What this trial is testing

Randomized Trial of Liposomal Amphotericin B for Histoplasmosis in AIDS Patients

Who this might be right for
HistoplasmosisAIDS
Alessandro Pasqualotto 118
Not applicableUnknownNCT06123832
What this trial is testing

Study of the Clinical Benefits of Different Formulations of Amphotericin B

Who this might be right for
EfficacySafety
Qianfoshan Hospital 184
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02273661
What this trial is testing

Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).

Who this might be right for
Allergic Bronchopulmonary Aspergillosis
Poitiers University Hospital 174
Large-scale testing (Phase 3)Study completedNCT02011958
What this trial is testing

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 59
Early research (Phase 1)Study completedNCT01652859
What this trial is testing

An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects

Who this might be right for
Normal Healthy Subjects
Taiwan Liposome Company 36
Large-scale testing (Phase 3)Study completedNCT00628719
What this trial is testing

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 400
Testing effectiveness (Phase 2)Study completedNCT00467883
What this trial is testing

Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment

Who this might be right for
Zygomycosis
Assistance Publique - Hôpitaux de Paris 40
Large-scale testing (Phase 3)Looking for participantsNCT03945448
What this trial is testing

Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia

Who this might be right for
Cryptococcal Meningitis
Makerere University 356
Large-scale testing (Phase 3)Study completedNCT00263315
What this trial is testing

Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis

Who this might be right for
Aspergillosis
Erasmus Medical Center 320
Not applicableLooking for participantsNCT03529617
What this trial is testing

Pharmacokinetics of Liposomal Amphotericin B in Critically Ill vs. Non-critically Ill Hematological Patients: Exploration of Covariates

Who this might be right for
PharmacokineticsLiposomal Amphotericin BCritically Ill Patients
Universitaire Ziekenhuizen KU Leuven 60
Load More Results